BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8733393)

  • 1. Minocycline-induced hyperpigmentation in leprosy.
    Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
    Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent serpentine supravenous hyperpigmented eruption in lepromatous leprosy after minocycline.
    Narang T; Dogra S; Sakia UN
    Lepr Rev; 2015 Jun; 86(2):191-4. PubMed ID: 26502692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline-induced hyperpigmentation in multibacillary leprosy.
    Hu SW; Robinson MR; Newlove T; Meehan S; Levis WR; Patel RR
    Am J Dermatopathol; 2012 Dec; 34(8):e114-8. PubMed ID: 23169418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case reports: minocycline-induced hyperpigmentation resolves during oral isotretinoin therapy.
    Soung J; Cohen J; Phelps R; Cohen SR
    J Drugs Dermatol; 2007 Dec; 6(12):1232-6. PubMed ID: 18189065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
    Levis WR; Spencer TI; Ladizinski B
    J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
    [No Abstract]   [Full Text] [Related]  

  • 7. Minocycline hyperpigmentation isolated to the subcutaneous fat.
    Rahman Z; Lazova R; Antaya RJ
    J Cutan Pathol; 2005 Aug; 32(7):516-9. PubMed ID: 16008698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser.
    Alster TS; Gupta SN
    Dermatol Surg; 2004 Sep; 30(9):1201-4. PubMed ID: 15355359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline-induced hyperpigmentation.
    Hung PH; Caldwell JB; James WD
    J Fam Pract; 1995 Aug; 41(2):183-5. PubMed ID: 7636458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
    Gelber RH; Murray LP; Siu P; Tsang M; Rea TH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline-induced skin pigmentation: an update.
    Geria AN; Tajirian AL; Kihiczak G; Schwartz RA
    Acta Dermatovenerol Croat; 2009; 17(2):123-6. PubMed ID: 19595269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser.
    Tsao H; Busam K; Barnhill RL; Dover JS
    Arch Dermatol; 1996 Oct; 132(10):1250-1. PubMed ID: 8859045
    [No Abstract]   [Full Text] [Related]  

  • 15. Minocycline-induced pigmentation of pre-existing capillaritis.
    Madan V; Lear JT
    Br J Dermatol; 2007 Mar; 156(3):590-1. PubMed ID: 17300262
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermacase. Minocycline-induced pigmentation.
    Kalia S; Adams SP
    Can Fam Physician; 2006 May; 52(5):595-6. PubMed ID: 16739831
    [No Abstract]   [Full Text] [Related]  

  • 18. Lepromatous leprosy: nasal manifestations and treatment with minocycline.
    Lalwani AK; Tami TA; Gelber RH
    Ann Otol Rhinol Laryngol; 1992 Mar; 101(3):261-4. PubMed ID: 1543336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting safety of minocycline as neuroprotection in Huntington's disease.
    Reynolds N
    Mov Disord; 2007 Jan; 22(2):292. PubMed ID: 17083098
    [No Abstract]   [Full Text] [Related]  

  • 20. Minocycline-induced pigmentation of the aortic valve and sinuses of Valsalva.
    Belcher E; Soni M; Azeem F; Sheppard MN; Petrou M
    Ann Thorac Surg; 2009 Nov; 88(5):1704. PubMed ID: 19853151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.